Sequoia Financial Advisors, LLC
Position in ORGO — Organogenesis Holdings Inc.
CIK 1599900
Akron, OH
Position in ORGO
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$32,887
New position
Shares Held
13,534
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 135 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $18,226,773 across 16 Drug Manufacturers - Specialty & Generic names. ORGO ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
190,940 | $6,469,047 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
162,082 | $2,348,568 | |
| 3 | VTRS |
Viatris Inc
|
93,790 | $1,489,385 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
87,929 | $1,409,501 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,530 | $1,370,829 | |
| 6 | ZTS |
Zoetis Inc.
|
18,476 | $1,327,685 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6,351 | $1,070,397 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
21,532 | $529,902 |
All Filings in ORGO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,887 | 13,534 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||